Lumos Pharma Inc
NASDAQ:LUMO

Watchlist Manager
Lumos Pharma Inc Logo
Lumos Pharma Inc
NASDAQ:LUMO
Watchlist
Price: 4.34 USD Market Closed
Market Cap: 37.5m USD

Intrinsic Value

LUMO's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one LUMO stock under the Base Case scenario is 16.83 USD. Compared to the current market price of 4.34 USD, Lumos Pharma Inc is Undervalued by 74%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

LUMO Intrinsic Value
16.83 USD
Undervaluation 74%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Lumos Pharma Inc

Valuation History Unavailable

Historical valuation for LUMO cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Lumos Pharma Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Lumos Pharma Inc

Current Assets 17.3m
Cash & Short-Term Investments 13.5m
Receivables 174k
Other Current Assets 3.6m
Non-Current Assets 187k
PP&E 187k
Efficiency

Free Cash Flow Analysis
Lumos Pharma Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Lumos Pharma Inc

Revenue
2.2m USD
Operating Expenses
-38.5m USD
Operating Income
-36.3m USD
Other Expenses
1.4m USD
Net Income
-34.9m USD
Fundamental Scores

LUMO Profitability Score
Profitability Due Diligence

Lumos Pharma Inc's profitability score is 20/100. The higher the profitability score, the more profitable the company is.

Exceptional Revenue Growth Forecast
Exceptional 1-Year Revenue Growth
Declining ROE
Declining ROIC
20/100
Profitability
Score

Lumos Pharma Inc's profitability score is 20/100. The higher the profitability score, the more profitable the company is.

LUMO Solvency Score
Solvency Due Diligence

Lumos Pharma Inc's solvency score is 51/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Low Altman Z-Score
51/100
Solvency
Score

Lumos Pharma Inc's solvency score is 51/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

LUMO Price Targets Summary
Lumos Pharma Inc

There are no price targets for LUMO.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Lumos Pharma Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for LUMO is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

LUMO Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one LUMO stock?

The intrinsic value of one LUMO stock under the Base Case scenario is 16.83 USD.

Is LUMO stock undervalued or overvalued?

Compared to the current market price of 4.34 USD, Lumos Pharma Inc is Undervalued by 74%.

Back to Top